======= PLSCR1 ======= == Gene Information == * **Official Symbol**: PLSCR1 * **Official Name**: phospholipid scramblase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5359|5359]] * **UniProt**: [[https://www.uniprot.org/uniprot/O15162|O15162]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PLSCR1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PLSCR1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604170|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: May mediate accelerated ATP-independent bidirectional transbilayer migration of phospholipids upon binding calcium ions that results in a loss of phospholipid asymmetry in the plasma membrane. May play a central role in the initiation of fibrin clot formation, in the activation of mast cells and in the recognition of apoptotic and injured cells by the reticuloendothelial system. |Scramblase| |phosphatidylserine biosynthetic process| |positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity| |regulation of DNA topoisomerase (ATP-hydrolyzing) activity| |CD4 receptor binding| |regulation of isomerase activity| |positive regulation of isomerase activity| |phospholipid scramblase activity| |regulation of Fc receptor mediated stimulatory signaling pathway| |plasma membrane phospholipid scrambling| |response to interferon-beta| |phosphatidylserine metabolic process| |epidermal growth factor receptor binding| |acute-phase response| |phospholipid translocation| |lipid translocation| |regulation of mast cell activation| |cellular modified amino acid biosynthetic process| |regulation of membrane lipid distribution| |positive regulation of ATPase activity| |negative regulation of viral genome replication| |acute inflammatory response| |negative regulation of viral life cycle| |regulation of ATPase activity| |phospholipid transport| |plasma membrane organization| |regulation of viral genome replication| |negative regulation of viral process| |organophosphate ester transport| |SH3 domain binding| |platelet activation| |regulation of viral life cycle| |defense response to virus| |cellular modified amino acid metabolic process| |regulation of viral process| |glycerophospholipid biosynthetic process| |negative regulation of multi-organism process| |regulation of symbiosis, encompassing mutualism through parasitism| |glycerolipid biosynthetic process| |membrane raft| |phospholipid biosynthetic process| |response to virus| |blood coagulation| |coagulation| |lipid transport| |hemostasis| |glycerophospholipid metabolic process| |lipid localization| |positive regulation of innate immune response| |enzyme binding| |positive regulation of response to biotic stimulus| |collagen-containing extracellular matrix| |phospholipid metabolic process| |glycerolipid metabolic process| |endomembrane system organization| |DNA-binding transcription activator activity, RNA polymerase II-specific| |regulation of innate immune response| |organic anion transport| |positive regulation of defense response| |wound healing| |regulation of body fluid levels| |inflammatory response| |positive regulation of multi-organism process| |regulation of response to biotic stimulus| |organophosphate biosynthetic process| |response to wounding| |lipid biosynthetic process| |anion transport| |positive regulation of response to external stimulus| |regulation of leukocyte activation| |regulation of cell activation| |perinuclear region of cytoplasm| |calcium ion binding| |regulation of defense response| |positive regulation of hydrolase activity| |regulation of multi-organism process| |membrane organization| |nucleolus| |positive regulation of immune response| |organophosphate metabolic process| |apoptotic process| |defense response to other organism| |cellular lipid metabolic process| |Golgi apparatus| |programmed cell death| |cell activation| |immune effector process| |cell death| |regulation of response to external stimulus| |response to cytokine| |regulation of immune response| |positive regulation of immune system process| |lipid metabolic process| |positive regulation of transcription by RNA polymerase II| |regulation of hydrolase activity| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |defense response| |ion transport| |integral component of plasma membrane| |organonitrogen compound biosynthetic process| |positive regulation of catalytic activity| |DNA binding| |regulation of response to stress| |positive regulation of transcription, DNA-templated| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |regulation of immune system process| |positive regulation of RNA metabolic process| |positive regulation of molecular function| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |membrane| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp18|Doxycycline 10μM R00 exp18]]|1.71| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15194 * **Expression level (log2 read counts)**: 4.58 {{:chemogenomics:nalm6 dist.png?nolink |}}